"We're on the threshold to using genomics and molecular technology to look at [mental illness] in a way we've never been able to do before," said Daniel Geschwind, a neurogeneticist at the University of California at Los Angeles and a leader of the study. "Psychiatric disorders have no obvious pathology in the brain, but now we have the genomic tools to ask what actually goes awry in these brains."